Drivetime Specialty is a free educational audio program covering a range of topics relevant to various medical specialists & physicians. Listen to our experienced medical broadcasters, moderating engaging discussions with leading experts.
Current programs include:
More disciplines coming soon……
Podcasts are available for each series – providing a time efficient form of communication that’s convenient and easy to consume. Click here for podcast download instructions
You can also listen online – either search by your area of interest to filter interviews relevant to you, or if you are logged in you can click on specific programs below.
Interviews are provided exclusively for Australian healthcare professionals. Subscribe for free today to access all programs.
NEW Neurology. How can we fill the gap between available therapies and more advanced technologies used to treat Parkinson’s? In this interview we discuss how to manage patients experiencing unpredictable off periods out in the community, as well as the involvement of movement disorder clinics and the necessary assistance and infrastructure.
NEW Neurology. Where do we go when patients continue to have symptoms? In this interview we discuss the practicalities of continuous infusions, intestinal gels and deep brain stimulation, including key considerations when deciding between them and the need for early identification and education.
NEW Respiratory. When you are seeing patients with asthma and airway disease in your clinical practice, if those patients are either; having frequent exacerbations or on maximum dose therapy, ask yourself, could this person have severe refractory eosinophilic asthma, and if so, could they benefit from one of the biologics? We review results from new long-term data that supports their use in clinical practice.
NEW Respiratory. As respiratory physicians we need to be across the latest information available, especially for patients with difficult to treat or severe asthma, the types of patients that are often referred to us for specialist assessment and management. This is where GINA, the Global Initiative for Asthma, comes in. In this interview we talk through the new GINA pocket guide in relation to strategies to treat severe asthma.
NEW Respiratory. In terms of difficult asthma, we’re in very exciting times! We now have the opportunity to substantially minimise exposure of patients to oral corticosteroids to try and minimise the burden of illness. In this interview we discuss identifying patients that would benefit from a reduction in oral corticosteroids, tips on down-titrating oral corticosteroids and starting patients on biologic agents.
NEW Respiratory. There are now three biologic agents for severe refractory asthma available in Australia. These agents when chosen appropriately can improve asthma control and decrease the risk of exacerbations. We need to ensure that these therapies are given to the right sort of patient, so what factors do we need to consider?
NEW Neurology. Making a diagnosis of epilepsy can be difficult, particularly establishing the difference between focal and generalised seizures, and this differential is critical. In this interview we discuss this, as well as how to ensure the patient gets the right treatment, early on.
NEW Neurology. One of the most difficult areas of practice for neurologists are the rules and regulations around driving with epilepsy. There’s a lot of confusion and immense interest in this topic, so in this interview we discuss the social consequences and the practical issues.
NEW Ophthalmology. Led by Diabetes Australia and Vision 2020 Australia, the NEW KeepSight initiative will engage with 1.27 million people with diabetes who are registered on the National Diabetes Services Scheme (NDSS). How will the KeepSight program ultimately change the management of diabetic retinopathy in Australia, and what do you as ophthalmologists need to do?
NEW Ophthalmology. New screening programs in Australia will help improve the detection rates of diabetic retinopathy, leading to earlier detection and treatment. Early detection and treatment can prevent the majority of vision loss and blindness in patients with diabetes, so how can we shift the care from what is now, very expensive hospital-based care, where ophthalmologists need laser treatment and intensive anti-VEFG injections, towards more primary and secondary care?
Tap the share icon and select 'Add to Home Screen' to add the site to your home screen for quick access!